Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Chimeric monoclonal antibody against claudin 6

EU orphan designation number: EU/3/12/1092   
Active ingredient: Chimeric monoclonal antibody against claudin 6
Indication: Treatment of ovarian cancer
Sponsor: Astellas Pharma Europe B.V.
Sylviusweg 62, 2333 BE Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2013 Orphan designation EMA/OD/147/12 (2013)481 of 24/01/2013
22/05/2017 Change of name and/or address of sponsor
28/03/2018 Transfer of orphan designation EMA/OD/147/12/T/01 (2018)2009 of 26/03/2018